About Diffinity Genomics
Diffinity Genomics is a Healthcare company based in West Henrietta (United States) founded in 2005, and was acquired by Chiral Technologies in August 2015. Genomics technologies are developed by Diffinity Genomics since 2005. Diffinity Genomics has raised $1.36 million across 9 funding rounds from investors including HHS, Chiral Technologies and Mass Medical Angels. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its competitors include Purigen Biosystems, Advanced Analytical Technologies and Molecular Staging; 2 of its 3 listed competitors have raised funding.
Company details
Diffinity Genomics was founded in 2005 and is based in West Henrietta, United States. Operations are centered in the genomics sector, where tools and methods for DNA amplification and analysis are provided. Services support research in molecular biology, with products accessible via diffinitygenomics.com. The focus remains on practical applications for scientific and diagnostic workflows in biotechnology.
- Headquarters West Henrietta, United States
- Stage Acquired
- SectorsHealthcare
- Website diffinitygenomics.com
- Social LinkedIn X
- Acquired by Chiral Technologies (Aug 2015)
- Total Equity Funding$1.36M (USD)
in 9 rounds
- Latest Funding Round$99.65K (USD), Grant
Aug 2012
- InvestorsHHS
& 2 more
- Acquired byChiral Technologies
(Aug 2015)
Funding Insights of Diffinity Genomics
Diffinity Genomics has successfully raised a total of $1.36M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $99.65 thousand completed in August 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.36M
- Total Rounds 9
- Last Round Grant — $99,647
- First Round $105,504
(Apr 2008)
- Investors Count 2
All 9 funding rounds of Diffinity Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Diffinity Genomics
Diffinity Genomics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Chiral Technologies and Mass Medical Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed stage investments are made in life sciences and healthcare. | 2010 | massmedangels.com | Boston, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Advanced chirality products and custom purification services | 1990 | chiraltech.com | West Chester, United States |
Investor details for Diffinity Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Diffinity Genomics
4 dated milestones of Diffinity Genomics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Diffinity Genomics is founded.
- Funding First funding round of $106K.
- Funding Latest funding round, Grant, of $100K.
- Exit Acquired by Chiral Technologies.
Competitors of Diffinity Genomics
Diffinity Genomics has 3 listed competitors in our database, 2 of them funded. They include Purigen Biosystems, Advanced Analytical Technologies and Molecular Staging.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| purigenbio.com | 2012 | Pleasanton, United States | $88.32M | 24 | Isotachophoresis technology is provided for nucleic acid sample preparation. | |
| aati-us.com | 1998 | Ankeny, United States | 5,968 | Instruments, software, and services for scientific laboratory management are provided. | ||
| molecularstaging.com | 1998 | New Haven, United States | $49.55M | Provides advanced molecular diagnostics and amplification for genomics and proteomics research. |
Detailed competitors of Diffinity Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Diffinity Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diffinity Genomics
Diffinity Genomics was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Diffinity Genomics is headquartered in West Henrietta, United States. It is registered at West Henrietta, New York, United States.
Diffinity Genomics is a funded company, having raised a total of $1.36M across 9 funding rounds to date. The company's 1st funding round was a Grant of $105.5K, raised on Apr 2008.
Diffinity Genomics was founded in 2005 and is based in West Henrietta, United States. Operations are centered in the genomics sector, where tools and methods for DNA amplification and analysis are provided. Services support research in molecular biology, with products accessible via diffinitygenomics.com. The focus remains on practical applications for scientific and diagnostic workflows in biotechnology.
Diffinity Genomics's top competitors include Purigen Biosystems, Advanced Analytical Technologies and Molecular Staging.
Diffinity Genomics has 3 investors. Key investors include HHS, Chiral Technologies, and Mass Medical Angels.
Yes. Diffinity Genomics was acquired by Chiral Technologies in August 2015.